Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0675
Bid: 0.065
Ask: 0.07
Change: 0.0025 (3.85%)
Spread: 0.005 (7.692%)
Open: 0.065
High: 0.0675
Low: 0.065
Prev. Close: 0.065
RBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update

10 May 2012 07:00

RNS Number : 0285D
Adventis Group PLC
10 May 2012
 



Adventis Group plc

 

(the "Group" or the "Company")

 

Update

 

The Company notes the recent fall in its share price and provides the following update. The Company released a trading update on 20 January 2012 (the "January Update") in which it stated that its bank indebtedness at 31 December 2011 was £2.2 million. Furthermore, it was expected that the realisation of retained net working capital following the sale of certain assets held by the Media division would generate net inflows of approximately £0.5 million, which would be used to reduce bank indebtedness. Current bank indebtedness is, as expected, lower than as at 31 December 2011 at approximately £1.5 million.

 

Since the January Update, the Company has been in discussions regarding an equity fundraising to raise net funds of approximately £3.0 million (the "Capital Raising") which would have been used to repay the Group's bank debt and for the partial satisfaction of the outstanding deferred consideration currently due to the vendors of Second2 Limited and bChannels Limited (the "Technology division"). Those vendors were also willing to participate significantly in the Capital Raising, becoming significant shareholders of the Company and agreeing a schedule of payments for the balance of deferred consideration not immediately settled.

 

However, despite the Company's efforts and the support of key shareholders, it has not proved possible in current market conditions to secure sufficient commitments from new investors to make the Capital Raising viable. The Directors have therefore concluded that the Company is unable to proceed with the Capital Raising.

 

Throughout the year to date, the Company has been in discussions with its bank, Lloyds Banking Group ("LBG"), regarding its facilities and future support. LBG has been fully supportive of the Capital Raising and remains supportive of the Company.

 

The Company is currently reviewing its options regarding the repayment of its bank debt and, with the support of LBG, is in the process of engaging advisers to assist in the sale of the Technology division. Any sale of the Technology division would be subject to obtaining shareholders' approval and the Board believes that the sale of the Technology division will realise sufficient funds to more than satisfy the LBG bank debt, although there is no certainty that this will be the case. If this were to be the case, the Company would become an investing company as defined in the AIM Rules for Companies and would seek shareholder approval for an appropriate investing policy. LBG has indicated that if insufficient funds were realised from a sale of the Technology division, it would take appropriate action to obtain repayment of outstanding sums, which may or may not include administration or an insolvency process.

 

A further announcement will be made in due course. The Company expects to release its preliminary results announcement for the year ended 31 December 2011 in early June 2012.

 

Nick Winks, Chairman, commented:

 

"Having tried, unsuccessfully, to persuade investors to back our efforts to raise new equity to pay down both bank and vendor debt, we are now working with our bank to find an alternative solution. We have two profitable and highly promising technology businesses which will now have to be sold to pay this historic debt. We believe that these businesses should be sold for an amount that is greater than that owed to the bank. "

 

Enquiries:

 

Adventis Group plc

Tel: 01494 731 600

Nick Winks, Chairman

 

Andy Pearson, Finance Director

 

 

 

Westhouse Securities Limited

Tel: 020 7601 6100

Tom Griffiths

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFEDEIIAIIF
Date   Source Headline
2nd Nov 20227:00 amRNSInvestor Presentation
1st Nov 20221:15 pmRNSCompletion of the Sale of Corallian to Shell
31st Oct 20229:08 amRNSPosting of Circular and Notice of Requisitioned GM
31st Oct 20227:00 amRNSPosting of Circular and Notice of Requisitioned GM
20th Oct 20227:00 amRNSRequisition of General Meeting
17th Oct 20221:00 pmRNSPurported Requisition of General Meeting
5th Oct 20223:30 pmRNSSPA for Sale of Corallian to Shell for £32 million
30th Sep 20227:00 amRNSUnaudited HY Results for 6 months ended 30/06/22
29th Sep 20227:02 amRNSPublication of PEDL183 CPR by RPS Energy
28th Sep 20227:00 amRNSConditional Acquisition of Simwell Resources
23rd Sep 20227:00 amRNSWest Newton Community Update on Planned Activity
23rd Sep 20227:00 amRNSWest Newton Community Update on Planned Activity
15th Sep 20227:00 amRNSAcquisition of North Sea Assets from Corallian
14th Sep 20227:00 amRNSAgreed Terms of Conditional Sale of Corallian
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
9th Sep 20227:00 amRNSResponse to Governmental Energy Plan
1st Sep 20227:00 amRNSUpdate on Corallian and acquisition of licences
14th Jul 20221:56 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSBoard Change
29th Jun 20224:31 pmRNSResults of Annual General Meeting
23rd Jun 20227:00 amRNSInvestor Presentation
21st Jun 20227:00 amRNSWest Newton Conceptual Development Plan
7th Jun 202211:53 amRNSNotice of AGM – correction of typographical error
1st Jun 202210:06 amRNSNotice of Annual General Meeting
27th May 20227:00 amRNSFull Year Results for the year ended 31 Dec 2021
26th May 20227:00 amRNSCompletion of Equity Exchange Agreement
24th May 20227:00 amRNSReabold North Sea – Presentation on New Licences
23rd May 20227:00 amRNSShareholder Approval Received for Equity Exchange
13th May 20227:00 amRNSAppointment of Chief Financial Officer
4th May 20227:00 amRNSOffer for Corallian and acquisition of licences
3rd May 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
17th Mar 202212:21 pmRNSPlanning Application Approval for Next Phase
25th Feb 20227:00 amRNSInvestor Presentation
25th Feb 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
24th Feb 20224:42 pmRNSSecond Price Monitoring Extn
24th Feb 20224:37 pmRNSPrice Monitoring Extension
17th Feb 202212:38 pmRNSAmendment of Existing Option Terms
25th Jan 20229:05 amRNSSecond Price Monitoring Extn
25th Jan 20229:00 amRNSPrice Monitoring Extension
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSWest Newton Flow Rate Update
23rd Dec 20217:00 amRNSVictory – Submission of Draft FDP
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSWest Newton – Rathlin’s Update to Residents
22nd Oct 20217:00 amRNSDirectors’ Dealings
21st Oct 20217:00 amRNSCreation of Enhanced California E&P Company
20th Oct 202111:05 amRNSSecond Price Monitoring Extn
20th Oct 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.